Tapan Maniar

Company: Oblenio Bio

Job title: Chief Medical Officer

Seminars:

Using A Dual-Target TCE Strategy to Eliminate BCMA+ & CD19+ Pathogenic Cells 4:00 pm

Presenting the scientific basis and emerging literature supporting the depletion of both plasma cells and memory B cells to achieve more complete and lasting immunomodulation. Understanding which B cell subsets drive pathology and how to measure depletion effectiveness Leveraging Preclinical & Translational Models to Evaluate Safety and Predict Toxicity Risks – Discussing the tools and…Read more

day: Day One